ABC | Volume 113, Nº1, Julho 2019

Posicionamento Posicionamento sobre Indicações da Ecocardiografia em Adultos – 2019 Arq Bras Cardiol. 2019; 113(1):135-181 onNutrition, Physical Activity, andMetabolism:endorsed by the American College of Cardiology Foundation. Circulation. 2007;115(12):1643-455. 120. Galderisi M, Cardim N, D'Andrea A, Bruder O, Cosyns B, Davin L, et al. The multi-modality cardiac imaging approach to the Athlete's heart:an expert consensus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(4):353. 121. Etchells E, Bell C, Robb K. Does this patient have an abnormal systolic murmur? JAMA. 1997;277(7):564-71. 122. Chizner MA. Cardiac auscultation:rediscovering the lost art. Curr Probl Cardiol. 2008;33(7):326-408. 123. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaborationwith the American Society of Echocardiography. Circulation. 1997;95(6):1686-744. 124. ShryEA,SmithersMA,MascetteAM.Auscultationversusechocardiography in a healthy population with precordial murmur. Am J Cardiol. 2001;87(12):1428-30. 125. Tavel ME. Cardiac auscultation. A glorious past--but does it have a future? Circulation. 1996;93(6):1250-3. 126. Siqueira VN, Mancuso FJ, Campos O, De Paola AA, Carvalho AC, Moises VA. Training program for cardiology residents to perform focused cardiac ultrasound examination with portable device. Echocardiography. 2015;32(10):1455-62. 127. Nishimura RA, Otto CM, BonowRO, Carabello BA, Erwin JP, 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1-132. 128. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ ACC Guideline for the Management of Patients With Valvular Heart Disease:A Report of the American College of Cardiology/AmericanHeart Association Task Force on Clinical Practice Guidelines. J AmColl Cardiol. 2017;70(2):252-89. 129. Harb SC, Griffin BP. Mitral valve disease:a comprehensive review. Curr Cardiol Rep. 2017;19(8):73. 130. Tsang W, Lang RM. Three-dimensional echocardiography is essential for intraoperative assessment of mitral regurgitation. Circulation. 2013;128(6):643-52;discussion 52. 131. Galli E, Lancellotti P, Sengupta PP,Donal E. LV mechanics in mitral and aortic valve diseases:value of functional assessment beyond ejection fraction. JACC Cardiovasc Imaging. 2014;7(11):1151-66. 132. Buck T, Plicht B. Real-Time three-dimensional echocardiographic assessment of severity of mitral regurgitation using proximal isovelocity surface area and vena contracta area method. Lessons we learned and clinical implications. Curr Cardiovasc Imaging Rep. 2015;8(10):38. 133. ZoghbiWA, Adams D, BonowRO, Enriquez-SaranoM, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation:a report from the american society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr. 2017;30(4):303-71. 134. Heo R, Son JW, B OH, Chang HJ, Kim YJ, Datta S, et al. Clinical implications of three-dimensional real-time color doppler transthoracic echocardiography in quantifying mitral regurgitation:a comparison with conventional two-dimensional methods. J Am Soc Echocardiogr. 2017;30(4):393-403 e7. 135. Casas-Rojo E, Fernandez-Golfin C, Moya-Mur JL, Gonzalez-Gomez A, Garcia-Martin A, Moran-Fernandez L, et al. Area strain from 3D speckle-tracking echocardiography as an independent predictor of early symptoms or ventricular dysfunction in asymptomatic severe mitral regurgitation with preserved ejection fraction. Int J Cardiovasc Imaging. 2016;32(8):1189-98. 136. Witkowski TG, Thomas JD, Debonnaire PJ, Delgado V, Hoke U, Ewe SH, et al. Global longitudinal strain predicts left ventricular dysfunction after mitral valve repair. Eur Heart J Cardiovasc Imaging. 2013;14(1):69-76. 137. Reyes VP, Raju BS, Wynne J, Stephenson LW, Raju R, Fromm BS, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med. 1994;331(15):961-7. 138. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Guyton RA, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease:a report of the American College of Cardiology/AmericanHeart Association Task Force on PracticeGuidelines. Circulation. 2014;129(23):e521-643. 139. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ ACC Guideline for the Management of Patients With Valvular Heart Disease:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(25):e1159-e95. 140. Evaluation of left ventricular structure and function. Arq Bras Cardiol. 2009;93(6 Suppl 3):e265-73. 141. Tarasoutchi F, MonteraMW, GrinbergM, PineiroDJ, Sanchez CR, Bacelar AC, et al. Brazilian Guidelines for Valve Disease - SBC 2011 / I Guideline Inter-American Valve Disease - 2011 SIAC. Arq Bras Cardiol. 2011;97(5 Suppl 1):1-67. 142. Karamnov S, Burbano-Vera N, Huang CC, Fox JA, Shernan SK. Echocardiographic assessment of mitral stenosis orifice area:a comparison of a novel three-dimensional method versus conventional techniques. Anesth Analg. 2017;125(3):774-80. 143. EstevesWAM, Lodi-Junqueira L, Soares JR, Sant'Anna AthaydeGR, Goebel GA, Carvalho LA, et al. Impact of percutaneous mitral valvuloplasty on left ventricular function in patients with mitral stenosis assessed by 3D echocardiography. Int J Cardiol. 2017 Dec;248:280-5. 144. Lancellotti P, Pellikka PA, Budts W, Chaudhry FA, Donal E, Dulgheru R, et al. The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease:Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(2):101-38. 145. Reis G, Motta MS, Barbosa MM, Esteves WA, Souza SF, Bocchi EA. Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosis. J AmColl Cardiol. 2004;43(3):393-401. 146. Baumgartner H, Falk V, Bax JJ, De Bonis M, HammC, HolmPJ, et al. 2017 ESC/EACTS Guidelines for themanagement of valvular heart disease:The Task Force for theManagement of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio- Thoracic Surgery (EACTS). Eur Heart J. 2017;38(36):2739-91. 147. Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, et al. Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis:A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(4):372-92. 148. Doherty JU, Kort S, Mehran R, Schoenhagen P, Soman P. ACC/AATS/AHA/ ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 AppropriateUse Criteria for Multimodality Imaging inValvular Heart Disease:AReport of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society forCardiovascularMagneticResonance,andSocietyofThoracicSurgeons. J Am Coll Cardiol. 2017;70(13):1647-72. 177